Nicams Purchase and Sale Agreement Sample Contracts

Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. AMENDMENT NO. 1 TO NICAMS PURCHASE AND SALE AGREEMENT May 26, 2016

Nicams Purchase and Sale Agreement • November 12th, 2020 • Hepion Pharmaceuticals, Inc. • Pharmaceutical preparations • British Columbia

• Contract Type
  Nicams Purchase and Sale Agreement
• Filed
  November 12th, 2020
• Company
  Hepion Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  British Columbia

THIS AMENDMENT NO. 1 (this “Amendment”) to the NCIAMs Purchase and Sale Agreement, is made and entered into as of May 26, 2016, by and between Aurinia Pharmaceuticals Inc., a Canadian corporation (“Aurinia”), Ciclofilin Pharmaceuticals Corp., an Alberta corporation (“CPC”), and Ciclofilin Pharmaceuticals, Inc., a Delaware corporation as successor in interest to Ciclofilin Pharmaceuticals Inc., a California corporation (“CPI”). Aurinia, CPI and CPC may each be referred to herein individually as a “Party” and collectively as the “Parties”.